PIK3R1 and breast carcinoma: PIK3R1 underexpression is an independent prognostic marker in breast cancers [27]. Silencing PIK3R1 enhanced the sensitivity of breast cancer cell lines to rapamycin [28], implicating a negative role of PIK3R1 in PI3K pathway activation.